Business Standard

Remus Pharmaceuticals Ltd - IPO

Issue Type

Book Building - SME

Issue Size (₹ Cr.)

47.69 cr

Price Range (₹)

1229

Lot Size

100

Min Investment (₹)

1,22,900.00

Listing Exchange

NSE - SME

Open Date

17-May-2023

Close Date

19-May-2023

Listing Date

29-May-2023

Remus Pharmaceuticals Ltd News

    The Shares of Remus Pharmaceuticals Ltd have now been listed.

    Remus Pharmaceuticals Ltd IPO Details

    Initial public issue of 388000 equity shares of face value of Rs. 10/- each of Remus Pharmaceuticals Limited (RPL or the Company or the Issuer) for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share (the Issue Price) aggregating to Rs. 47.69 crores (The Issue), of which 19500 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share aggregating to Rs. 2.40 crores will be reserved for subscription by market maker to the issue (the Market Maker Reservation Portion). The issue less the market maker reservation portion i.e. net issue of 368500 equity shares of face value of Rs. 10/- each at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share aggregating to Rs. 45.29 crores is herein after referred to as the Net Issue. The issue and the net issue will constitute 26.34% and 25.02%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each.

    Objective of issue

    To Meet Working Capital Requirements. Funding investments for acquisitions & general corporate purposes.

    Remus Pharmaceuticals Ltd Contact Details

    Remus Pharmaceuticals Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083

    Phone - 91-22-49186000

    Fax - 91-22-49186060

    Email - cs@remuspharma.com

    Website - https://www.remuspharma.com